Prevalence and factors associated with uptake of pre-exposure prophylaxis amongst women vulnerable to HIV who received HIV antibodies in Antibody Mediated Prevention HVTN703/HPTN081 trial in Harare, Zimbabwe: a cross-sectional study
Introduction There is limited evidence on pre-exposure prophylaxis (PrEP) uptake post-trial participation for women vulnerable to HIV. This study investigates the prevalence and factors associated with PrEP uptake post-participation in an HIV prevention trial.Methods Former Antibody Mediated Prevent...
Saved in:
Main Authors: | Bernard Ngara, Bekezela Siziba, Nyaradzo Mavis Mgodi, Tariro Dianah Chawana, Miria Chitukuta, Pamela Grace Mukwekwerere, Muchaneta Bhondai-Mhuri, Zvavahera Mike Chirenje, Felix Godwin Sivukile Mhlanga |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-04-01
|
Series: | BMJ Public Health |
Online Access: | https://bmjpublichealth.bmj.com/content/2/1/e000262.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084
by: Sinead Delany‐Moretlwe, et al.
Published: (2025-01-01) -
Optimal Treatment Strategies for HIV with Antibody Response
by: Yinggao Zhou, et al.
Published: (2014-01-01) -
An Unusual Case of Anti-GBM Antibody Elevation in HIV-Associated Nephropathy
by: Vinay Minocha, et al.
Published: (2014-01-01) -
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
by: Gamze Isitman, et al.
Published: (2012-01-01) -
Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01)